IM Cannabis Corp. is welcoming the German government's final approval legalizing cannabis, as well as the landmark medical cannabis act that has the potential to facilitate access for many new patients as of April 1 . The regulatory rescheduling of cannabis along with the expected market growth provides IMC with a unique growth opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 CAD | -1.85% | -10.92% | +130.43% |
May. 08 | Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+130.43% | 10.39M | |
+36.66% | 4.09B | |
+131.68% | 2.18B | |
+131.75% | 76.48M |
- Stock Market
- Equities
- IMCC Stock
- News IM Cannabis Corp.
- IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis